Pathogenic variants of KCNC1 are associated with severe neurological phenotypes, including myoclonic epilepsy, ataxia, intellectual disability without epilepsy, and developmental and epileptic encephalopathy (Ambrosino et al., 2023; Clatot et al., 2023). Here, KCNC1 is linked to epilepsy.